|
COVER
Full Text:
CiNii
|
|
|
Chemical & Pharmaceutical Bulletin(Information)
Full Text:
CiNii
|
i
|
|
CONTENTS
Full Text:
CiNii
|
ii-vi
|
|
About the cover
Full Text:
CiNii
|
vi
|
|
Author Index
Full Text:
CiNii
|
vii
|
|
Determination of Diclofenac Sodium in Commercial Pharmaceutical Formulations and Human Control Serum Using a Kinetic-Spectrophotometric Method
Full Text:
CiNii
|
1423-1426
|
|
Optimization of an HPLC Method for Determination of Gabapentin in Dosage Forms through Derivatization with 1-Fluoro-2, 4-dinitrobenzene
Full Text:
CiNii
|
1427-1430
|
|
Study of Compounds Suppressing Free Radical Generation from UV-Exposed Ketoprofen
Full Text:
CiNii
|
1431-1438
|
|
Selective Synthesis and Utility of One Tripyrrolic Compound and Its Intermediates
Full Text:
CiNii
|
1439-1441
|
|
Apotirucallane and Tirucallane Triterpenoids from Cedrela sinensis
Full Text:
CiNii
|
1442-1447
|
|
Application of Polyglycolized Glycerides in Protection of Amorphous Form of Etoricoxib during Compression
Full Text:
CiNii
|
1448-1451
|
|
The Suppression of Enhanced Bitterness Intensity of Macrolide Dry Syrup Mixed with an Acidic Powder
Full Text:
CiNii
|
1452-1457
|
|
Preparation of New Nitrogen-Bridged Heterocycles. 60. Syntheses and Conformational Analyses of Bis(indolizin-1-yl) Disulfides
Full Text:
CiNii
|
1458-1465
|
|
Improvement of Dissolution Properties of a New Helicobacter pylori Eradicating Agent (TG44) by Inclusion Complexation with β-Cyclodextrin
Full Text:
CiNii
|
1466-1470
|
|
Xeniaphyllane-Derived Terpenoids from the Formosan Soft Coral Sinularia gibberosa
Full Text:
CiNii
|
1471-1475
|
|
Estrogenic and Anti-estrogenic Activities of Cassia tora Phenolic Constituents
Full Text:
CiNii
|
1476-1482
|
|
Electroreduction of the Muscle Relaxant Drug Dantrolene Sodium at the Mercury Electrode and Its Determination in Bulk Form and Pharmaceutical Formulation
Full Text:
CiNii
|
1483-1488
|
|
Catalytic Aerobic Oxidation of nor-Binaltorphimine (nor-BNI) Analogs without 4, 5-Epoxy Bridge Affords a More Selective Ligand for κ Opioid Receptor than the Representative κ Antagonist nor-BNI
Full Text:
CiNii
|
1489-1493
|
|
Cinnamylindoline Derivatives : Synthesis and Factor Xa (FXa) Inhibitory Activities
Full Text:
CiNii
|
1494-1504
|
|
Bioactive Constituents from Chinese Natural Medicines. XXVI : Chemical Structures and Hepatoprotective Effects of Constituents from Roots of Rhodiola sachalinensis
Full Text:
CiNii
|
1505-1511
|
|
Microbial Metabolism. Part 8 : The Pyranocoumarin, Decursin
Full Text:
CiNii
|
1512-1513
|
|
A Facile Synthesis of p- and m-(Amidinomethyl)phenyl Esters Derived from Amino Acid and Tryptic Hydrolysis of These Synthetic Inverse Substrates
Full Text:
CiNii
|
1514-1517
|
|
Chemical Phenotypes of the hmg1 and hmg2 Mutants of Arabidopsis Demonstrate the In-planta Role of HMG-CoA Reductase in Triterpene Biosynthesis
Full Text:
CiNii
|
1518-1521
|
|
Marked Production of Ginsenosides Rd, F_2, Rg_3, and Compound K by Enzymatic Method
Full Text:
CiNii
|
1522-1527
|
|
Compositions of Royal Jelly II : Organic Acid Glycosides and Sterols of the Royal Jelly of Honeybees (Apis mellifera)
Full Text:
CiNii
|
1528-1531
|
|
Clerodane Diterpenoids and Flavonoids with NGF-Potentiating Activity from the Aerial Parts of Baccharis gaudichaudiana
Full Text:
CiNii
|
1532-1534
|
|
Resveratrol Tetramers with a C_6-C_3 or a C_1 Unit from Upuna borneensis
Full Text:
CiNii
|
1535-1539
|
|
Selective Hydrogenation of Alkene in (3-Trifluoromethyl) Phenyldiazirine Photophor with Wilkinson's Catalyst for Photoaffinity Labeling
Full Text:
CiNii
|
1540-1543
|
|
Chemical & Pharmaceutical Bulletin投稿規定
Full Text:
CiNii
|
A1-A3
|
|
Chemical & Pharmaceutical Bulletin Instructions for Authors
Full Text:
CiNii
|
B1-B3
|
|
The Pharmaceutical Society of Japan Overseas Membership Application
Full Text:
CiNii
|
|
|
BACKCOVER
Full Text:
CiNii
|
|
